mokko lactone has been researched along with Cardiotoxicity in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdallah, HM; Abdel-Naim, AB; Alamoudi, AJ; Eid, BG; Elfaky, MA; Ibrahim, SRM; Mohamed, GA; Shaik, RA; Sirwi, A | 1 |
1 other study(ies) available for mokko lactone and Cardiotoxicity
| Article | Year |
|---|---|
Mokko Lactone Alleviates Doxorubicin-Induced Cardiotoxicity in Rats via Antioxidant, Anti-Inflammatory, and Antiapoptotic Activities.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cardiotoxicity; Doxorubicin; Myocardium; Oxidative Stress; Rats; Sesquiterpenes | 2022 |